Poultry Vaccine Market expected to reach USD 2,698.1 million by 2030
Poultry Vaccine Market Trends & Forecast
According to a research study published by Knowledge Sourcing Intelligence (KSI), the poultry vaccine market will expand from USD 2,202.673 million in 2025 to USD 2,698.100 million in 2030 at a CAGR of 4.14% during the forecast period.
The rapidly growing poultry production worldwide and the growing incidence of several poultry diseases are driving this global market. As the demand for poultry products increases, so does the awareness of the health risks associated with consuming diseased poultry. This heightened awareness is prompting poultry manufacturers to regularly vaccinate their flocks, positively influencing the global poultry vaccine market growth.
National governments and international organizations are increasingly taking steps to reduce the risk of disease transmission due to poultry animals by regulating poultry farming and ensuring biosecurity. Governments are implementing strict biosecurity regulations, taking up disease control programs like vaccination programs, and framing rules and policies to regulate poultry farming. The rules and regulations regarding vaccination are increasing the market for global poultry vaccines.
Request a free sample copy or view the report summary: Global Poultry Vaccine Market Report
Poultry Vaccine Market Report Highlights
- Recombinant vaccines use specific antigens like proteins, providing a strong immunization response, and are effective against diseases like Newcastle disease, infectious bronchitis, and Avian influenza. These vaccines can target specific antigens, making them a safer option and reducing the risk of side effects. These vaccines are compatible with mass immunization methods, making them a more suitable option for poultry farmers. Thus, Recombinant Vaccines are anticipated to dominate the poultry vaccine market in the forecast period as the demand for safer immunization methods and enhanced immunity is growing.
- The Attenuated Live Vaccines segment dominates the global poultry vaccine market, primarily because of their proven efficacy, rapid immune response, and long-lasting protection against a wide range of poultry diseases. These vaccines are widely adopted for high-burden diseases such as Newcastle disease, infectious bronchitis, and Marek’s disease, making them the backbone of poultry immunization programs worldwide.
- Region-wise, the global market is segmented into Asia-Pacific, North America, South America, Europe, the Middle East, and Africa. North America accounted for a significant share of the global poultry vaccine market. Increasing consumption of poultry-related food products has boosted poultry production in the region. This has led to concerns about the safety of poultry food products due to the rising incidence of avian diseases, augmenting the demand for poultry vaccines in the region. Moreover, the presence of major market players in the region is contributing to the poultry vaccine’s growth.
Report Coverage:
| Report Metric | Details |
| Poultry Vaccine Market Size in 2025 | US$2,202.673 million |
| Poultry Vaccine Market Size in 2030 | US$2,698.1 million |
| Growth Rate | CAGR of 4.14% |
| Drivers |
|
| Restraints |
|
| Segmentation |
|
| List of Major Companies in the Poultry Vaccine Market |
|
Poultry Vaccine Market Growth Drivers and Restraints
Growth Drivers:
- Growing Poultry Population: The growing poultry population is anticipated to lead the market growth of poultry vaccines. The demand for poultry is growing globally as consumers prefer more of it in their diet than ever before. Owing to its high nutritional value in terms of protein, the demand for poultry food is growing. As the global population grows, the demand for poultry due to their diet preference also increases.
- Increasing Demand to Prevent Disease in Poultry: The demand for poultry vaccines is increasing due to many factors. One such reason is the increased prevalence of diseases affecting poultry, like Marek’s disease and Newcastle disease. These diseases are zoonotic, i.e., they are transferable to humans as well. Past decades have seen disease outbreaks from poultry affecting millions of human lives. For instance, a recent outbreak of Avian Influenza Virus was reported in five geographic regions, including North & South America, Europe, Asia, and Africa, impacting millions of birds and raising health concerns in humans. Thus, the need for vaccination in poultry is on the rise, and governments and organizations worldwide are implementing new rules and regulations and vaccination awareness to prevent disease outbreaks. Hence, the poultry vaccination market will rise in the forecast period.
Poultry Vaccine Market Key Development
- Product Innovation: In June 2025, Boehringer Ingelheim, a global leader in animal health, announced the launch of its latest poultry vaccine in India, a single-dose, next-generation solution that provides protection against Bursal, Newcastle, and Marek’s disease.
- Product Launch: In May 2025, MSD Animal Health, a division of Merck & Co., Inc., announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for the INNOVAX®-ND-IBD-ILT vaccine.
Poultry Vaccine Market Segmentation
Knowledge Sourcing Intelligence has segmented the Global Poultry Vaccine Market based on disease type, product, and region:
Poultry Vaccine Market, by Disease Type
- Avian Influenza
- Marek’s Diseases
- Bronchitis
- Others
Poultry Vaccine Market, by Product
- Inactivated Vaccines
- Attenuated Live Vaccines
- Recombinant Vaccines
- Others
Poultry Vaccine Market, By Region
- North America
- USA
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Others
- Asia Pacific
- China
- India
- Japan
- South Korea
- Taiwan
- Thailand
- Indonesia
- Others
- South America
- Brazil
- Argentina
- Others
- Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- Others
Poultry Vaccine Market Key Players
- Zoetis Inc.
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale
- Merck & Co. Inc.
- AniCon Labor GmbH
- Hester Biosciences Limited
- Elanco Animal Health Incorporated
- Biovac S.A.
- Phibro Animal Health Corporation
- Salfarm Danmark A/S
